LRCX Stock Charts

Quarterly

Annual

Unit: USD	2025-09-28	2025-06-29	2025-03-30	2024-12-29	2024-09-29	2024-06-30	2024-03-31	2023-12-24	2023-09-24	2023-06-25	2023-03-26	2022-12-25	2022-09-25	2022-06-26	2022-03-27	2021-12-26	2021-09-26	2021-06-27	2021-03-28	2020-12-27	2020-09-27	2020-06-28	2020-03-29	2019-12-29	2019-09-29	2019-06-30	2019-03-31	2018-12-23	2018-09-23	2018-06-24	2018-03-25	2017-12-24	2017-09-24	2017-06-25	2017-03-26	2016-12-25	2016-09-25	2016-06-26	2016-03-27	2015-12-27	2015-09-27	2015-06-28	2015-03-29	2014-12-28	2014-09-28	2014-06-29	2014-03-30	2013-12-29	2013-09-29	2013-06-30	2013-03-31	2012-12-23	2012-09-23	2012-06-24	2012-03-25	2011-12-25	2011-09-25	2011-06-26	2011-03-27	2010-12-26	2010-09-26	2009-09-27	2009-06-28	2009-03-29	2008-12-28	2008-09-28	2008-06-29	2008-03-30	2007-12-23	2007-09-23	2007-06-24	2007-03-25	2006-12-24	2006-09-24	2006-06-25	2006-03-26	2005-12-25	2005-09-25	2005-06-26	2005-03-27	2004-12-26	2004-09-26	2004-06-27	2004-03-28	2003-12-28	2003-09-28	2003-06-29

cash flows from operating activities:
net income	1,568,660,000	1,720,088,000	1,330,667,000	1,191,018,000	1,116,444,000	1,020,282,000	965,826,000	954,266,000	887,398,000	802,537,000	814,008,000	1,468,507,000	1,425,879,000	1,208,934,000	1,021,778,000	1,194,830,000	1,179,744,000	1,144,657,000	1,071,121,000	869,229,000	823,451,000	696,673,000	574,781,000	514,510,000	465,789,000	541,825,000	547,390,000	568,855,000	533,360,000	1,021,146,000	778,800,000	-9,955,000	590,690,000	526,424,000	574,713,000	332,791,000	263,835,000	258,939,000	143,451,000	222,980,000	288,679,000	131,271,000	206,285,000	176,940,000	141,081,000	233,395,000	164,396,000	148,992,000	85,506,000	85,707,000	18,996,000	6,408,000	2,768,000	18,069,000	45,604,000	33,212,000	71,838,000	125,928,000	182,240,000	221,856,000	193,724,000	16,797,000	-88,490,000	-198,359,000	-24,172,000	8,873,000	72,178,000	103,524,000	115,059,000	148,588,000	170,231,000	164,741,000	167,326,000	183,518,000	122,149,000	86,337,000	77,778,000	49,491,000	66,526,000	59,451,000	83,614,000	89,750,000	52,655,000	19,156,000	6,391,000	4,786,000	3,699,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	101,644,000	98,439,000	97,343,000	96,200,000	94,295,000	88,357,000	89,922,000	90,941,000	90,479,000	89,604,000	91,663,000	85,414,000	75,751,000	87,932,000	84,228,000	81,705,000	79,874,000	78,397,000	79,453,000	76,389,000	72,912,000	71,083,000	67,248,000	65,530,000	64,664,000	65,408,000	82,274,000	81,794,000	79,805,000	85,119,000	82,236,000	79,898,000	79,142,000	79,036,000	76,242,000	77,065,000	74,562,000	74,976,000	73,664,000	71,798,000	70,590,000	70,177,000	70,322,000	69,536,000	67,885,000	71,115,000	73,256,000	73,552,000	74,331,000	76,051,000	74,861,000	78,388,000	74,816,000	34,576,000	22,517,000	22,372,000	21,360,000	19,972,000	18,176,000	18,663,000	17,948,000	17,681,000	17,694,000	19,650,000	17,177,000	17,896,000	19,227,000	12,914,000	11,324,000	11,239,000	10,920,000	11,890,000	8,760,000	6,527,000	5,765,000									6,031,000	7,478,000	8,462,000	8,249,000
deferred income taxes	-62,875,000	-151,679,000	-19,992,000	-82,854,000	-108,722,000	-61,375,000	-24,621,000	-88,747,000	-24,238,000	-38,960,000	7,195,000	-6,680,000	-133,616,000	-173,987,000	-56,878,000	-13,550,000	-13,023,000	-146,029,000	-1,136,000	-2,462,000	-1,850,000	-92,293,000	0	77,508,000	-2,992,000	70,125,000	-12,401,000	20,797,000	-83,501,000	212,260,000	19,060,000	-271,478,000	43,204,000	35,069,000	27,619,000	34,615,000	7,633,000	-46,708,000	-4,908,000	8,176,000	-5,563,000	-2,694,000	1,739,000	3,320,000	3,186,000	-4,104,000	-816,000			-22,884,000	-27,934,000	-7,320,000	-12,017,000	39,356,000	3,723,000			-6,166,000	-733,000	-3,039,000	-783,000	12,482,000	19,913,000	12,929,000	10,110,000	-12,407,000	-4,652,000	-11,995,000	776,000	-10,790,000	8,334,000	-5,122,000	7,424,000	6,419,000	-4,936,000	17,935,000	-647,000	15,374,000	51,187,000	-13,413,000	21,954,000	29,624,000	7,417,000	2,669,000	876,000	-100,000	-3,214,000
equity-based compensation expense	97,241,000	94,286,000	87,115,000	81,959,000	80,011,000	79,092,000	76,854,000	69,901,000	67,211,000	68,495,000	73,911,000	73,084,000	71,110,000	69,588,000	68,543,000	62,834,000	58,099,000	56,321,000	55,746,000	52,109,000	55,988,000	53,153,000	47,414,000	45,725,000	42,905,000	44,845,000	53,240,000	38,806,000	50,343,000	47,214,000	41,095,000	42,124,000	41,783,000	43,802,000	35,323,000	32,255,000	38,595,000	39,288,000	34,716,000	32,570,000	35,774,000	39,734,000	32,948,000	30,632,000	32,040,000	33,085,000	24,334,000	23,046,000	23,235,000	25,241,000	25,648,000	24,027,000	24,414,000	29,174,000	16,417,000	18,224,000	17,744,000	14,788,000	12,456,000	12,759,000	13,009,000	13,958,000	13,358,000	10,227,000	14,049,000	15,408,000	11,629,000	10,272,000	9,813,000	10,802,000	11,766,000	10,873,000	6,664,000	6,251,000
other	-1,890,000	14,240,000	1,654,000	-8,592,000	-457,000	-3,999,000	10,210,000	4,182,000	-150,000	40,761,000	1,559,000	12,729,000	-2,751,000	33,574,000	-3,121,000	-66,514,000	-8,690,000	-23,535,000	-2,047,000	5,273,000	2,917,000	-10,822,000	7,811,000	-327,000	4,026,000	-5,055,000	-1,494,000	-1,343,000	2,191,000	10,933,000	17,866,000	-1,108,000	6,569,000	8,275,000	-4,738,000	-1,292,000	16,807,000	17,929,000	10,256,000	10,592,000	10,011,000	3,621,000	1,902,000	1,607,000	5,526,000	8,241,000	2,741,000	-2,428,000	4,115,000	4,550,000	6,115,000	16,317,000	8,406,000	7,206,000	1,367,000	881,000	1,423,000	477,000	746,000	-1,600,000	-1,964,000	1,159,000	2,535,000	953,000	3,200,000	2,665,000	2,074,000	-15,157,000	9,303,000	461,000	-237,000	1,597,000	-614,000	537,000	839,000	-1,517,000	-694,000	1,046,000	-448,000	547,000	-797,000	267,000	-973,000	-82,000	-347,000	1,151,000	918,000
changes in operating assets and liabilities	76,184,000		-188,124,000	-535,789,000	386,900,000		266,645,000	423,297,000	-69,537,000		738,102,000	-492,867,000	-246,785,000		-356,840,000	181,201,000	-838,480,000		-39,469,000	-657,318,000	-312,329,000		-157,187,000	-396,593,000	-112,020,000		260,951,000	-67,521,000	136,843,000		64,524,000	184,684,000	92,330,000		-292,607,000	-113,863,000	64,962,000		-95,776,000	-75,207,000	39,702,000		-131,142,000	-129,947,000	-109,092,000		13,986,000	-135,441,000	-150,388,000		-6,931,000	66,542,000	143,123,000		51,406,000	88,680,000	-34,215,000		25,259,000	-62,849,000	37,829,000
net cash from operating activities	1,778,964,000	2,554,188,000	1,308,663,000	741,942,000	1,568,471,000	862,430,000	1,384,836,000	1,453,840,000	951,163,000	1,122,725,000	1,726,438,000	1,140,187,000	1,189,588,000	443,934,000	757,710,000	1,440,506,000	457,524,000	1,435,935,000	1,165,080,000	344,637,000	642,511,000	813,048,000	541,428,000	307,928,000	464,047,000	880,487,000	932,821,000	642,419,000	720,286,000	718,358,000	1,050,379,000	28,704,000	858,306,000	729,272,000	422,688,000	404,098,000	473,224,000	423,824,000	182,911,000	294,545,000	448,997,000	292,066,000	191,037,000	161,239,000	141,161,000	245,891,000	290,210,000	129,023,000	51,925,000	174,988,000	102,457,000	193,226,000	249,262,000	96,715,000	146,397,000	169,016,000	86,900,000	198,108,000	241,593,000	185,583,000	255,744,000	2,704,000	-58,120,000	-24,152,000	-38,989,000	43,132,000	200,447,000	145,985,000	21,440,000	222,447,000	293,493,000	151,401,000	162,038,000	216,627,000	92,266,000	109,635,000	111,405,000	47,381,000	133,884,000	101,299,000			82,404,000	40,579,000
cash flows from investing activities:
capital expenditures and intangible assets	-185,121,000	-172,191,000	-288,058,000	-188,349,000	-110,588,000	-100,748,000	-103,654,000	-115,276,000	-76,992,000	-78,670,000	-119,457,000	-163,378,000	-140,063,000	-125,746,000	-145,368,000	-138,493,000	-136,427,000	-104,622,000	-89,596,000	-92,072,000	-62,806,000	-50,554,000	-51,375,000	-62,054,000	-39,256,000	-65,948,000	-75,522,000	-105,923,000	-56,098,000	-79,655,000	-49,057,000	-84,693,000	-60,064,000	-34,811,000	-44,116,000	-36,513,000	-41,979,000	-51,726,000	-46,007,000	-28,143,000	-49,454,000								-23,778,000	-43,140,000	-34,766,000	-38,924,000	-43,965,000	-36,880,000	-27,978,000	-26,682,000	-15,732,000	-34,571,000	-35,769,000	-38,025,000	-19,130,000	-5,832,000	-5,848,000	-10,866,000	-12,417,000	-15,151,000	-18,951,000	-19,291,000	-24,417,000	-14,144,000	-14,305,000	-18,777,000	-13,966,000	-12,920,000
free cash flows	1,593,843,000	2,381,997,000	1,020,605,000	553,593,000	1,457,883,000	761,682,000	1,281,182,000	1,338,564,000	874,171,000	1,044,055,000	1,606,981,000	976,809,000	1,049,525,000	318,188,000	612,342,000	1,302,013,000	321,097,000	1,331,313,000	1,075,484,000	252,565,000	579,705,000	762,494,000	490,053,000	245,874,000	424,791,000	814,539,000	857,299,000	536,496,000	664,188,000	638,703,000	1,001,322,000	-55,989,000	798,242,000	694,461,000	378,572,000	367,585,000	431,245,000	372,098,000	136,904,000	266,402,000	399,543,000								28,147,000	131,848,000	67,691,000	154,302,000	205,297,000	59,835,000	118,419,000	142,334,000	71,168,000	163,537,000	205,824,000	147,558,000	236,614,000	-3,128,000	-63,968,000	-35,018,000	-51,406,000	27,981,000	181,496,000	126,694,000	-2,977,000	208,303,000	279,188,000	132,624,000	148,072,000	203,707,000
net cash from investing activities	-186,048,000	-129,251,000	-292,915,000	-175,375,000	-110,551,000	-101,613,000	-92,360,000	-101,958,000	-74,683,000	-55,180,000	-84,332,000	-267,247,000	-127,803,000	-75,937,000	-94,564,000	186,083,000	596,693,000	689,061,000	115,936,000	69,940,000	-801,666,000	-430,209,000	169,772,000	-734,329,000	750,682,000	-623,483,000	-1,008,171,000	666,931,000	-672,331,000	1,261,280,000	2,085,864,000	-294,813,000	-303,891,000		-467,250,000	-2,027,217,000	376,752,000	521,514,000	135,731,000	14,395,000	-79,157,000	-340,456,000	-394,636,000	-378,875,000	7,871,000	-74,513,000	-95,810,000	-113,830,000	18,939,000	-60,710,000	-47,273,000	-70,197,000	-60,457,000	711,461,000	-310,200,000	-30,561,000	-100,974,000	-351,368,000	-47,258,000	-37,641,000	-43,646,000	-23,139,000	44,750,000	3,572,000	-15,591,000	-26,726,000	-40,747,000	-366,451,000	-58,478,000	-30,129,000											-50,257,000	-22,446,000
cash flows from financing activities:
principal payments on debt, including finance lease obligations and payments for debt issuance costs	-1,417,000
treasury stock purchases, including excise tax payments	-975,791,000		-435,321,000
dividends paid	-291,981,000	-295,207,000	-295,716,000	-297,634,000	-260,985,000	-261,462,000	-262,707,000	-264,414,000	-230,332,000	-232,335,000	-233,977,000	-235,980,000	-205,615,000	-208,056,000	-210,587,000	-211,216,000	-185,431,000	-185,385,000	-186,551,000	-187,927,000	-167,129,000	-167,739,000	-163,510,000	-166,721,000	-158,868,000	-164,873,000	-171,196,000	-167,907,000	-174,372,000	-82,005,000	-79,739,000	-73,127,000	-72,738,000	-73,709,000	-73,337,000	-48,397,000	-48,052,000	-47,308,000	-47,539,000	-47,896,000	-47,659,000	-28,714,000	-28,724,000	-29,381,000	-29,240,000
proceeds from issuance of common stock, net issuance costs			1,993,000	-194,000	-43,000
net cash from financing activities	-1,281,638,000	-1,509,537,000	-1,232,555,000	-935,230,000	-1,259,321,000	-574,151,000	-1,235,793,000	-859,894,000	-1,326,012,000	-1,037,986,000	-819,528,000	-662,212,000	-310,941,000	-1,023,534,000	-1,549,708,000	-578,103,000	-1,427,592,000	-1,381,774,000	-1,288,406,000	-865,317,000	-631,485,000	563,400,000	225,462,000	-1,150,696,000	-262,096,000	-1,527,856,000	1,643,522,000	-515,553,000	-1,990,193,000	-2,160,769,000	-186,462,000	-396,022,000	-528,804,000	-539,809,000	-333,819,000	-1,729,258,000	-29,508,000	1,861,887,000	-57,160,000	-85,736,000	-123,246,000	-87,557,000	862,635,000	-90,769,000	-305,837,000	-11,373,000	-34,502,000	-40,215,000	-76,645,000	26,950,000	-221,330,000	-348,542,000	-344,868,000	-653,001,000	67,596,000	30,302,000	-137,644,000	699,994,000	14,724,000	-51,533,000	-136,199,000	4,398,000	8,687,000	-240,051,000	-39,451,000	9,985,000				25,647,000	-738,992,000	-258,679,000							-75,374,000	-18,870,000	30,986,000	10,939,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	-7,059,000		2,380,000	-26,022,000	22,682,000		-8,452,000	6,725,000	-11,031,000		-2,302,000	17,878,000	-16,925,000		-5,090,000	-4,678,000	-3,776,000		-5,756,000	8,187,000	4,082,000		-10,715,000	5,055,000	-4,193,000		4,128,000	-2,721,000	-2,311,000
net change in cash, cash equivalents, and restricted cash	304,219,000		-214,427,000	-394,685,000	221,281,000		48,231,000
cash, cash equivalents, and restricted cash at beginning of period	6,407,656,000		0	0	5,850,803,000		0	0	5,587,372,000		0	0	3,773,535,000		0	0	4,670,750,000		0	0	5,169,083,000		0	0	3,913,396,000		0	0	4,768,558,000
cash, cash equivalents, and restricted cash at end of period	6,711,875,000		-214,427,000	-394,685,000	6,072,084,000		48,231,000	498,713,000	5,126,809,000		820,276,000	228,606,000	4,507,454,000		-891,652,000	1,043,808,000	4,293,599,000		-13,146,000	-442,553,000	4,382,525,000		925,947,000	-1,572,042,000	4,861,836,000		1,572,300,000	791,076,000	2,824,009,000
schedule of non-cash transactions:
accrued payables for stock repurchases, including applicable excise tax	58,827,000	21,558,000	-3,548,000	-42,807,000	63,322,000	14,608,000	-400,000
accrued payables for capital expenditures	95,745,000	-6,492,000	5,136,000	29,952,000	52,203,000	15,704,000	-18,004,000	24,458,000	38,668,000	-6,326,000	-56,269,000	15,321,000	79,173,000	22,366,000	-38,495,000	30,308,000	66,117,000	-18,823,000	7,933,000	34,549,000	37,733,000	8,122,000	1,724,000	-2,367,000	30,333,000	-4,098,000	-9,299,000	-31,000	36,613,000	-8,609,000	3,579,000	-5,500,000	34,531,000	7,208,000	-14,139,000	12,585,000	11,631,000
dividends payable	327,507,000	-3,442,000	-619,000	-1,592,000	297,634,000	-558,000	-1,670,000	-1,907,000	265,040,000	-1,776,000	-934,000	-2,003,000	235,980,000	-2,442,000	-2,530,000	-629,000	211,216,000	41,000	-1,221,000	-1,435,000	188,046,000	-611,000	4,230,000	-3,211,000	166,721,000	-6,006,000	-6,322,000	3,289,000	167,907,000	92,342,000	2,287,000	6,616,000	73,127,000	-1,215,000	615,000	24,941,000	48,397,000
transfers of finished goods inventory to property and equipment	22,897,000	16,313,000	15,759,000	25,816,000	32,985,000	15,977,000	17,363,000	19,913,000	18,014,000	11,924,000	8,000,000	36,134,000	20,798,000	12,952,000	6,794,000	39,804,000	15,518,000
reconciliation of cash, cash equivalents, and restricted cash
cash and cash equivalents	6,693,046,000	939,941,000	-214,661,000	-402,092,000	6,067,471,000	175,624,000	48,943,000	497,139,000	5,126,150,000	31,408,000	820,932,000	228,217,000	4,256,499,000	-672,718,000	-891,825,000	1,044,393,000	4,042,151,000	744,897,000	-13,799,000	-441,902,000	4,129,067,000	953,586,000	925,699,000	-1,571,295,000	4,607,182,000	-1,273,392,000	1,571,818,000	791,708,000	2,568,085,000
restricted cash and cash equivalents	18,829,000	4,743,000	234,000	7,407,000	4,613,000	1,426,000	-712,000	1,574,000	659,000	-372,000	-656,000	389,000	250,955,000	498,000	173,000	-585,000	251,448,000
total cash, cash equivalents, and restricted cash	6,711,875,000	944,684,000	-214,427,000	-394,685,000	6,072,084,000	177,050,000	48,231,000	498,713,000	5,126,809,000	31,036,000	820,276,000	228,606,000	4,507,454,000	-672,220,000	-891,652,000	1,043,808,000	4,293,599,000	743,924,000	-13,146,000	-442,553,000	4,382,525,000	953,342,000	925,947,000	-1,572,042,000	4,861,836,000	-1,273,989,000	1,572,300,000	791,076,000	2,824,009,000
changes in operating asset and liability accounts:
accounts receivable, net of allowance
inventories
prepaid expenses and other assets
trade accounts payable
deferred profit
accrued expenses and other liabilities
business acquisitions, net of cash acquired										0	0
proceeds from maturities of available-for-sale securities
proceeds from sales of available-for-sale securities						0				0
principal payments on long-term debt and finance lease obligations and payments for debt issuance costs
treasury stock purchases					-997,035,000	-373,550,000	-980,561,000	-645,458,000	-843,238,000	-869,014,000	-581,943,000	-456,276,000	-109,779,000	-876,089,000	-1,338,006,000	-414,815,000	-1,236,753,000	-431,255,000	-1,094,571,000	-723,297,000	-448,581,000	-41,017,000	-245,433,000	-1,005,067,000	-78,132,000	-1,108,560,000	-934,637,000	-1,519,000	-1,735,895,000	-1,306,309,000	-80,105,000	-1,111,450,000	-155,385,000	-525,778,000	-216,372,000	-67,668,000	-1,854,000	-27,114,000	-20,092,000	-12,798,000	-98,385,000	-74,339,000	-124,943,000	-65,536,000	-308,422,000	-40,249,000	-52,415,000	-47,910,000	-104,285,000	-2,275,000	-243,297,000	-355,010,000	-355,079,000	-661,059,000	-18,909,000	-20,642,000	-72,053,000	-53,753,000	-8,617,000	-4,151,000	-144,795,000	-2,356,000	-3,197,000	-546,000	-24,448,000	-2,755,000	-3,590,000	-737,000	-761,000	-9,464,000	-768,400,000	-239,012,000	-75,285,000	-1,048,000	-37,002,000	-73,602,000	-61,917,000	-78,690,000	-99,288,000								0
reissuances of treasury stock related to employee stock purchase plan																																										16,950,000	14,934,000	0	16,919,000	14,597,000	13,210,000	-35,000	15,154,000	12,846,000	8,494,000	0	9,925,000		7,902,000	0	8,858,000
proceeds from issuance of common stock						2,796,000	8,235,000	1,704,000	2,818,000	3,438,000	0	877,000	6,796,000	997,000	492,000	3,451,000	742,000	851,000	9,626,000	8,108,000	5,538,000	1,869,000	1,714,000	632,000	3,869,000	1,694,000	5,010,000			2,626,000	2,517,000	3,073,000	1,042,000	369,000	7,964,000	3,121,000	1,459,000	1,547,000	308,000	1,173,000	377,000	1,285,000	7,403,000	4,223,000	4,609,000	8,657,000	5,111,000	8,449,000	12,574,000	16,713,000	15,132,000	6,583,000	951,000	0	301,000	1,311,000	164,000	2,179,000	5,980,000	3,407,000	835,000	2,256,000	6,287,000	1,283,000	1,294,000	3,150,000	2,588,000	0	3,398,000	6,708,000	12,175,000	5,892,000	22,662,000	1,739,000	43,698,000	61,602,000	61,926,000	12,174,000	23,456,000	48,923,000	30,986,000	10,939,000	9,290,000	6,658,000	31,068,000	17,136,000	8,523,000
effect of exchange rate changes on cash, cash equivalents and restricted cash
net change in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
schedule of non-cash transactions
supplemental disclosures:
cash payments for interest
cash payments for income taxes
proceeds from maturities of available-for-sales securities							11,220,000	15,841,000	7,275,000		32,577,000	17,743,000	14,695,000
reissuance of treasury stock related to employee stock purchase plan			0				0				0				0				0				0				0				0				17,223,000	0	19,320,000				19,245,000
principal payments on debt, including finance lease obligations				-1,032,000	-934,000		-1,060,000	-986,000	-253,109,000
purchases of available-for-sale securities														0	-299,362,000	-243,160,000	-25,297,000	-146,647,000	-790,525,000	-702,028,000	-1,750,188,000	-1,007,804,000	-270,128,000	-1,472,063,000	-147,632,000	-954,361,000	-1,190,500,000	-35,359,000	-749,829,000	-155,370,000	-125,973,000	-826,079,000	-1,425,407,000	-987,791,000	-1,223,150,000	-2,332,761,000	-38,149,000	-30,184,000	-36,522,000	-449,438,000	-358,854,000	-929,956,000	-1,092,989,000	-726,763,000	-337,100,000	-488,312,000	-364,642,000	-302,881,000	-156,409,000	-265,043,000	-204,839,000	-405,887,000	-222,187,000	-244,792,000	-404,061,000	-76,526,000	-158,050,000	-431,823,000	-51,746,000	-29,958,000	-50,958,000	-29,638,000	-10,987,000	-54,644,000	-18,259,000	-125,408,000	-158,039,000	-51,169,000	-49,617,000	-52,048,000	-6,170,000	-413,094,000	-319,609,000	-319,208,000	-89,133,000	-11,616,000	-17,829,000	-10,886,000	-67,575,000	-45,925,000	-68,906,000	-64,986,000	-45,001,000	-107,690,000	38,769,000	-349,554,000	-310,729,000
net increase in cash, cash equivalents, and restricted cash									-460,563,000		820,276,000	228,606,000	733,919,000								-786,558,000				948,440,000				-1,944,549,000
accrued payables for stock repurchases									37,768,000		-26,044,000	30,037,000	88,000	-4,578,000	-15,479,000	19,977,000	126,000	14,150,000	-17,191,000	4,447,000	18,599,000	-213,000	6,000	276,000	13,000	-1,608,000	1,633,000	-158,000	162,000	-2,049,000			4,350,000		-6,110,000
net increase in cash, cash equivalents and restricted cash
principal payments on debt											-2,209,000	-17,082,000	-1,854,000		-1,821,000	-1,698,000	-6,338,000		-16,245,000	-4,596,000	-19,173,000		-617,637,000	-17,987,000	-28,965,000		-30,225,000	-6,440,000	-79,831,000
net proceeds from issuance of long-term debt																																																														284,000	0	0	498,000	127,000	1,915,000
proceeds from borrowings on revolving credit facility																						0								0	0
repayment of borrowings on revolving credit facility
maturities of available-for-sales securities															33,027,000	27,260,000	106,836,000		662,031,000	691,754,000	597,252,000		211,228,000	351,980,000	600,347,000
sales of available-for-sale securities															345,519,000	541,071,000	656,504,000		362,023,000	178,376,000	415,862,000		270,059,000	457,796,000	337,763,000																																																											240,139,000	-59,058,000	250,375,000
net decrease in cash, cash equivalents, and restricted cash																	-377,151,000
net (repayment) from commercial paper
amortization of note discounts and issuance costs																			1,412,000	1,417,000	1,422,000	1,329,000	1,361,000	1,575,000	1,675,000	2,206,000	2,861,000	1,031,000	1,245,000	959,000	4,342,000	4,539,000	4,588,000	6,114,000	6,136,000	6,202,000	6,830,000	14,584,000	22,458,000	23,649,000	9,831,000
transfers of inventory to property and equipment																			10,134,000	20,729,000	29,019,000		6,683,000	13,475,000	13,997,000		8,796,000	8,110,000	25,613,000		8,901,000	18,125,000	11,852,000		12,144,000
restricted cash and investments																			653,000	-651,000	253,458,000	-244,000	248,000	-747,000	254,654,000	-597,000	482,000	-632,000	255,924,000
impairment of investments
business acquisition, net of cash acquired																														0	0	-84,000	-115,613,000
principal payments on long-term debt and capital lease obligations and payments for debt issuance costs																														-178,279,000	-228,166,000	-47,522,000	-301,727,000	-2,445,000	-69,227,000	-1,616,270,000	-371,000		-8,479,000
net (repayment) proceeds from commercial paper
net repayments of commercial paper
proceeds from issuance of long-term debt, net of issuance costs
income tax benefit on equity-based compensation plans																																						-8,048,000	1,312,000	2,168,000	3,545,000		2,438,000	1,141,000	9,861,000									1,429,000	-1,048,000	470,000	659,000	9,283,000	15,327,000	-918,000	5,083,000	-89,000	-1,173,000	-11,115,000	-7,045,000	5,039,000	26,815,000	-520,000	21,277,000	35,900,000	12,621,000	27,577,000	20,367,000	1,872,000
excess tax benefits on equity-based compensation plans
(gains) losses on extinguishment of debt
gain on sale of assets
proceeds from sale of assets																																														134,762,000	0			0	0			0	0			0	0
impairment of investment																																																		0				0	0	0	1,724,000
net (repayments) proceeds from issuance of commercial paper																											297,850,000
repayments of borrowings on revolving credit facility																															0
sales and maturities of available-for-sale securities																												808,582,000	137,246,000		2,260,859,000	620,378,000	1,307,633,000	1,081,649,000	804,584,000	341,833,000	469,899,000	636,075,000	218,460,000	488,640,000	330,651,000	651,577,000	733,573,000	405,173,000	346,745,000	333,277,000	281,898,000	214,127,000	198,976,000	258,601,000	192,764,000	382,637,000	205,549,000	574,481,000	121,836,000	72,332,000	72,791,000	115,034,000	40,678,000	28,798,000	26,452,000	19,863,000	104,043,000	88,605,000	58,026,000	132,388,000	125,545,000	134,370,000	33,717,000	36,063,000	546,246,000	349,945,000	-21,165,000	228,285,000	179,429,000	38,319,000	32,020,000	62,484,000	32,010,000	76,901,000	27,494,000	47,678,000					338,546,000
net repayments from issuance of commercial paper																													-86,000
income tax benefit (expense) on equity-based compensation plans
excess tax (benefits) expense on equity-based compensation plans
transfer of restricted cash and investments																																					-5,219,000							100,000	22,000	-637,000	28,572,000	0	150,000	-328,000	-32,000	33,000	146,000	-29,000	3,000	3,000	17,000	-8,000	-4,000	0	-10,000	-6,571,000	-44,458,000	558,000	-32,178,000	-16,128,000	17,233,000	-688,000			0	55,000,000
net proceeds from issuance of commercial paper																														-638,367,000
excess tax benefits (expense) on equity-based compensation plans
effect of exchange rate changes on cash and cash equivalents																														-5,607,000	4,041,000	842,000	3,317,000	399,000	2,991,000	-5,364,000	1,911,000	76,000	2,666,000	344,000	-3,808,000
net increase in cash and cash equivalents																														-186,738,000			28,928,000	248,964,000	-375,390,000	-3,357,741,000	822,379,000	2,807,301,000	264,148,000	223,548,000	242,786,000	-134,097,000				160,376,000								154,485,000	-96,661,000	167,610,000	-152,814,000	549,422,000	213,650,000	100,779,000	82,514,000	-13,004,000			-92,519,000	12,895,000			-17,113,000	219,201,000	79,160,000	-134,310,000	-402,231,000	120,533,000	152,970,000	124,063,000	118,964,000	32,568,000	45,788,000	110,289,000	133,444,000	29,326,000
cash and cash equivalents at beginning of year																																																																							0	0			0	0
cash and cash equivalents at end of year
loss on extinguishment of debt																																		-73,000	0
transfers of restricted cash and investments																															-603,000	61,000	160,000		-982,000
cash and cash equivalents at beginning of period																															0	0	2,377,534,000		0	0	5,039,322,000		0	0	1,501,539,000		0	0	1,452,677,000		0	0	1,162,473,000		0	0	1,564,752,000		0	0	1,492,132,000		0	0	545,767,000	374,167,000		0	0	732,537,000		0	0	573,967,000				910,815,000				482,250,000		0	0	163,403,000		0	0	167,343,000
cash and cash equivalents at end of period																															2,953,822,000	-661,289,000	2,406,462,000		-375,390,000	-3,357,741,000	5,861,701,000		264,148,000	223,548,000	1,744,325,000		654,361,000	-312,403,000	1,293,678,000		159,746,000	-23,629,000	1,156,184,000		-171,080,000	-221,277,000	1,411,466,000		-96,661,000	167,610,000	1,339,318,000		213,650,000	100,779,000	628,281,000	361,163,000		-278,265,000	-92,519,000	745,432,000		-223,702,000	-17,113,000	793,168,000		-134,310,000	-402,231,000	1,031,348,000				514,818,000		110,289,000	133,444,000	192,729,000		179,868,000	42,551,000	86,660,000
net proceeds from commercial paper
net decrease in cash and cash equivalents																																												-312,403,000	-158,999,000			-23,629,000	-6,289,000				-153,286,000																																42,551,000	-80,683,000
impairment of long-lived assets
gain on sale of business																																										0	0	0	-7,431,000
goodwill impairment																																																															7,179,000
purchase of other investments																																																										0				-961,000	0				0	0
proceeds from sale of business																																										0	0	0	41,212,000
net cash (used by) provided by investing activities
(issuance) repayment of notes receivable																																			0
schedule of noncash transactions:
excess tax benefit on equity-based compensation plans																																						9,035,000	-2,262,000	-2,181,000	-3,572,000		-2,204,000	-599,000	-10,404,000	-5,769,000								-394,000	-137,000	-204,000	-1,951,000	-8,184,000	-11,878,000	711,000	-3,939,000	-368,000	-237,000	7,027,000	3,752,000	-4,269,000	-21,666,000	401,000	-16,488,000	-21,151,000	-10,449,000	-19,191,000	-14,086,000	-1,264,000
transfers of inventory to (from) property and equipment																																					13,419,000
principal payments on long-term debt and capital lease obligations																																									-96,000	-615,000	-119,000	-674,000	-107,000	-739,000	-112,000	-719,000	-88,000	-698,000	-756,000	-115,000	-665,000	-1,101,000	-1,024,000	-1,576,000	-1,564,000	-81,000	-1,038,000	-78,000	-3,333,000	-1,915,000	-911,000	-239,703,000	-13,043,000	-2,390,000	-1,500,000	-250,114,000	-51,000	-49,000	-51,000	-50,048,000	-50,028,000	-44,000
schedule of noncash transactions
repayment of notes receivable																																							-200,000				0
re-issuance of treasury stock related to employee stock purchase plan																																							16,387,000
excess tax (benefit) expense on equity-based compensation plans
gain on sale of real estate
issuance (repayment) of notes receivable
excess tax benefit (expense) on equity-based compensation plans																																										-1,809,000
impairment of long-lived asset																																															4,000,000	628,000	7,004,000
amortization of convertible note discount																																											8,749,000	8,609,000	8,509,000	8,411,000	8,313,000	8,217,000	8,122,000	8,028,000	7,935,000	7,843,000	7,752,000	7,014,000	6,750,000	6,671,000	6,593,000
capital expenditures																																											-31,898,000	-61,363,000	-41,871,000		-41,638,000																													-6,447,000	-5,036,000	-4,658,000	-4,226,000	-4,640,000	-8,845,000	-5,138,000	-13,015,000	-4,799,000	-4,423,000	-1,789,000	-2,736,000
cash paid for business acquisition																																											0	0	-1,137,000		0				-400,000
purchases of other investments
(uses of) transfer to restricted cash and investments
proceeds from issuance of long-term debt, net issuance costs
effect of exchange rate changes on cash																																											-4,675,000	-3,998,000	-2,194,000	371,000	-152,000	1,393,000	-508,000	2,136,000	-4,934,000	4,236,000	2,777,000	-690,000	-454,000	-1,147,000	-1,096,000	2,688,000	4,591,000	4,370,000	6,615,000	3,033,000	4,202,000	-17,634,000	1,512,000	-13,496,000	-1,857,000	-1,984,000	851,000	1,236,000	-112,000	-106,000	1,144,000	-152,000	1,740,000	1,724,000	-1,605,000	-374,000	-361,000	1,524,000	2,350,000	451,000	839,000	318,000	1,008,000	-12,000	1,478,000
cash acquired in (paid for) business acquisition
purchase of equity method and other investments
receipt of loan payments																																																						0	0
net cash received in settlement of stock repurchase contracts
repayments of notes receivable																																															0
restructuring charges																																																										16,742,000	0	0	-5,163,000	2,093,000																	0				0	995,000	4,869,000	812,000	9,142,000
net proceeds from issuance of long-term debt & convertible notes
proceeds from sale of warrants
purchase of convertible note hedge
net cash received in settlement of (paid in advance for) stock repurchase contracts
restructuring and impairment charges																																																			0				0	-859,000	1,725,000
income tax impact on equity-based compensation plans
excess tax impact on equity-based compensation plans
purchase of equity method investment																																																						0	0
receipt of loan payment
net cash paid in advance for stock repurchase contracts
cash acquired in business acquisition
reissuances of treasury stock																																																										7,518,000	6,521,000	0	7,155,000	5,761,000	6,271,000	5,942,000	0	7,584,000	1,262,000	0	0	7,301,000	6,835,000	5,298,000	0	5,990,000	5,519,000	4,515,000	0	5,137,000					4,185,000	4,631,000	0	4,426,000	4,051,000
acquisition of leased equipment																																																																											0
net cash received in settlement (paid in advance for) stock repurchase contracts																																																							79,189,000	51,005,000	-75,000,000
loss on equity method investment
acquisitions of business, net of cash acquired
loans made
cash paid in advance for stock repurchase contracts																																																											0
adjustments to reconcile net income to net cash from by operating activities:
net gain on settlement of call option																																																																			-145,000
changes in operating asset accounts:
acquisitions of businesses, net of cash acquired																																																															0	-8,267,000	-8,763,000	-2,427,000	-6,918,000
purchase of call option																																																																			0
proceeds from settlement of call option																																																																			383,000
changes in operating asset and liabilities:																																																														-61,009,000
adjustments to reconcile net income to net cash provided (used for) by operating activities:
sales of other investments
restructuring and asset impairments																																																																23,245,000	17,849,000	19,016,000
changes in operating asset accounts																																																																22,215,000	-73,909,000	-9,089,000		79,266,000	-130,260,000	46,482,000
net cash from / (used for) financing activities																																																																			22,341,000	-1,252,000						7,901,000	379,607,000	-7,552,000	9,000	-61,379,000
amortization of premiums/discounts on securities																																																																				974,000	636,000	916,000	834,000	-438,000	-937,000	-117,000
acquisitions of businesses
changes in working capital accounts:
schedule of noncash transactions acquisition of leased equipment
changes in working capital accounts																																																																								-40,526,000	-32,866,000	12,884,000
payments made for the acquisition of bullen ultrasonics, inc. assets																																																																								0
net cash from / (used for) investing activities																																																																								-26,926,000	-476,848,000	-103,843,000	-320,643,000	20,256,000	9,155,000	46,940,000
amortization of premiums on securities																																																																											431,000	653,000	803,000	796,000	671,000	761,000	926,000	927,000	1,008,000	985,000			1,573,000
asset impairment charge
loss on disposal of long-lived assets
net noncash gain on retirement of 4% notes
proceeds from settlement of swap
stock-based compensation																																																																												6,029,000	6,044,000	5,246,000
income tax benefit from stock option exercises
change in working capital accounts																																																																												-5,010,000	23,126,000	-30,604,000			37,708,000	-86,407,000		10,543,000	14,115,000	-19,069,000
payments on capital lease
depreciation																																																																													5,356,000	5,640,000	5,659,000	6,130,000	6,470,000	5,408,000
amortization																																																																													-361,000	392,000	646,000	194,000	224,000	786,000
loss on equity derivative contracts in company stock
amortization of deferred stock-based compensation																																																																															497,000	74,000	266,000	27,000	116,000	282,000	0	2,769,000
tax benefit from employee stock options
transfer of restricted cash
purchase of investments for restricted cash																																																																																							970,000
change in other working capital accounts
net cash (used for)/provided by investing activities
principal payments and redemptions on long-term debt and capital lease obligations																																																																																				0	-1,000	-11,000
adjustments to reconcile net income to net cash provided by/(used for) operating activities:
net cash provided by/(used for) operating activities																																																																																		40,382,000				-1,189,000
patent settlement
sales of accounts receivable
transfer of restricted cash upon settlement of swap
net cash provided by/(used for) investing activities																																																																																					-24,879,000	-101,033,000
net cash provided by/(used for) financing activities																																																																																			-275,655,000	11,289,000
restricted cash released upon settlement of equity derivatives in company stock
net cash provided by/ (used for) financing activities																																																																																						21,551,000
cumulative effect of change in accounting principle, eitf 00-19
cumulative effect of change in accounting principle, sab 101 net of tax
purchased technology for research and development
strategic investments
net proceeds from issuance of debt
gain on equity derivative contracts in company stock
amortization of deferred compensation

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.